• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer.

作者信息

Bien Jeffrey, Lin Albert

机构信息

Divisions of Hematology and Medical Oncology, Stanford Cancer Institute, Stanford, California.

Division of Oncology, VA Palo Alto Health Care System, Palo Alto, California.

出版信息

JAMA. 2021 Jun 15;325(23):2404-2405. doi: 10.1001/jama.2021.6021.

DOI:10.1001/jama.2021.6021
PMID:34129003
Abstract
摘要

相似文献

1
A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer.转移性结直肠癌的诊断与治疗综述
JAMA. 2021 Jun 15;325(23):2404-2405. doi: 10.1001/jama.2021.6021.
2
A Review of the Diagnosis and Treatment of Metastatic Colorectal Cancer-Reply.转移性结直肠癌的诊断与治疗综述——回复
JAMA. 2021 Jun 15;325(23):2405. doi: 10.1001/jama.2021.6027.
3
Low intensity treatment in metastatic colorectal cancer.转移性结直肠癌的低强度治疗。
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):97-99. doi: 10.1016/S2468-1253(22)00380-6. Epub 2022 Dec 2.
4
[Colorectal cancers: surgery of non-metastatic colonic and rectal cancer].[结直肠癌：非转移性结肠癌和直肠癌的手术治疗]
Pathol Biol (Paris). 2004 Apr;52(3):117-8. doi: 10.1016/j.patbio.2003.12.005.
5
Cancer Data Service: colorectal carcinoma distantly metastatic at diagnosis, 1945-1974.癌症数据服务：1945 - 1974年诊断时发生远处转移的结直肠癌
J Kans Med Soc. 1977 Jun;78(6):290-1.
6
Heterogeneity in Microsatellite Instability in Metastatic Colorectal Cancer: Mechanisms and Clinical Implications.转移性结直肠癌微卫星不稳定性的异质性：机制与临床意义
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1263-1264. doi: 10.6004/jnccn.2019.7348.
7
Who Should Undergo Transplant for Metastatic Colorectal Cancer?: A Shift in Treatment Paradigm.谁应该接受转移性结直肠癌的移植治疗？治疗模式的转变。
JAMA Surg. 2021 Jun 1;156(6):557. doi: 10.1001/jamasurg.2021.0268.
8
Resection of metastatic colorectal cancer to the liver.转移性结直肠癌肝转移灶切除术。
Surgery. 1981 Oct;90(4):796-8.
9
Thinking outside the box: a more efficient diagnostic approach in metastatic colorectal cancer.跳出框框思考：转移性结直肠癌更有效的诊断方法
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):494-495. doi: 10.1016/S2468-1253(19)30092-5. Epub 2019 May 9.
10
Durable complete response to immunotherapy in treatment-resistant metastatic colorectal cancer with thyroid transcription factor 1 expression.甲状腺转录因子1表达的难治性转移性结直肠癌对免疫疗法的持久完全缓解。
ANZ J Surg. 2020 Nov;90(11):E97-E99. doi: 10.1111/ans.15810. Epub 2020 Mar 6.

引用本文的文献

1
EPS8L2 drives colorectal cancer cell proliferation and migration via YBX1-dependent activation of G3BP2 transcription.EPS8L2通过YBX1依赖性激活G3BP2转录来驱动结肠癌细胞的增殖和迁移。
Cell Death Dis. 2025 Aug 10;16(1):605. doi: 10.1038/s41419-025-07929-x.
2
Adoptive cellular immunotherapy combined with chemotherapy versus chemotherapy alone in Chinese patients with metastatic colorectal cancer: a cost-effectiveness analysis to inform drug pricing.中国转移性结直肠癌患者接受过继性细胞免疫疗法联合化疗与单纯化疗的比较：一项为药物定价提供参考的成本效益分析
Front Oncol. 2025 Jun 9;15:1590319. doi: 10.3389/fonc.2025.1590319. eCollection 2025.
3
Digestive cancers: mechanisms, therapeutics and management.
消化系统癌症：机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
4
METTL3‑mediated N6‑methyladenosine modification of MMP9 mRNA promotes colorectal cancer proliferation and migration.METTL3 介导的 MMP9 mRNA 的 N6‑甲基腺苷修饰促进结直肠癌的增殖和迁移。
Oncol Rep. 2025 Jan;53(1). doi: 10.3892/or.2024.8842. Epub 2024 Nov 14.
5
Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges.基于无机纳米粒子的结直肠癌治疗方法：最新进展与挑战。
J Nanobiotechnology. 2024 Jul 19;22(1):427. doi: 10.1186/s12951-024-02701-3.
6
Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer.利用三级淋巴结构基因特征评估结直肠癌中的肿瘤微环境浸润和免疫治疗反应。
Front Oncol. 2024 May 23;14:1383096. doi: 10.3389/fonc.2024.1383096. eCollection 2024.
7
NAT10-mediated acC modification promotes stemness and chemoresistance of colon cancer by stabilizing NANOGP8.NAT10介导的乙酰化修饰通过稳定NANOGP8促进结肠癌的干性和化疗耐药性。
Heliyon. 2024 Apr 25;10(9):e30330. doi: 10.1016/j.heliyon.2024.e30330. eCollection 2024 May 15.
8
XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.XELOX（卡培他滨加奥沙利铂）联合贝伐珠单抗（抗 VEGF-A 抗体）与或不与过继细胞免疫治疗联合用于治疗未经治疗的转移性结直肠癌患者：一项多中心、开放标签、随机、对照、III 期临床试验。
Signal Transduct Target Ther. 2024 Apr 3;9(1):79. doi: 10.1038/s41392-024-01788-2.
9
The tsRNAs (tRFdb-3013a/b) serve as novel biomarkers for colon adenocarcinomas.tsRNAs（tRFdb-3013a/b）可作为结直肠腺癌的新型生物标志物。
Aging (Albany NY). 2024 Mar 6;16(5):4299-4326. doi: 10.18632/aging.205590.
10
Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression.RNA N4-乙酰胞苷在癌症进展中潜在作用的最新进展。
Cell Commun Signal. 2024 Jan 17;22(1):49. doi: 10.1186/s12964-023-01417-5.